Compare SNDA & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNDA | HTFL |
|---|---|---|
| Founded | 1990 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 1997 | 2025 |
| Metric | SNDA | HTFL |
|---|---|---|
| Price | $40.25 | $47.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $35.75 | ★ $38.20 |
| AVG Volume (30 Days) | 441.5K | ★ 1.8M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $381,141,000.00 | $176,034,000.00 |
| Revenue This Year | $68.73 | $27.66 |
| Revenue Next Year | $11.11 | $23.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 25.24 | ★ 39.92 |
| 52 Week Low | $24.95 | $20.13 |
| 52 Week High | $44.39 | $47.23 |
| Indicator | SNDA | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 86.33 |
| Support Level | $38.45 | $24.59 |
| Resistance Level | $43.74 | N/A |
| Average True Range (ATR) | 1.64 | 2.15 |
| MACD | -0.06 | 2.20 |
| Stochastic Oscillator | 32.24 | 95.95 |
Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.